Clinical OMICs - Volume 3, Issue 3 - (Page 3)
Molecular Diagnostics in Personalized Medicine
Variants identified in a
multigene panel test can seem
like the dots in a connectthe-dots puzzle-only many
of the dots are unnumbered.
Regardless, patterns are
emerging in clinical cancer
genetics.
CLINICAL ACTIONABILITY IN CANCER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
Interpreting mutations piled higher and deeper.
LIQUID BIOPSY THRUSTS NON-INVASIVE
MOLECULAR DIAGNOSTICS INTO THE CLINICAL ARENA . . . . . . . . . . . . . . . . . . .11
Two experts in the emerging field of liquid biopsy share
their visions for the future of diagnostic medicine.
EPIGENETICS RESEARCH REVEALS
A RANGE OF CLINICAL POSSIBILITIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
Advantageously, epigenetic analyses can capture both
genetic factors and environmental exposures.
PCR HAS A HISTORY OF AMPLIFYING ITS GAME . . . . . . . . . . . . . . .21
A brief timeline of how PCR ascended to
the pinnacle of molecular methodologies.
Regular Features
CASE STUDY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .25
Designing Amplicon Panels Bioo Scientific asserts that amplicon sequencing
can benefit from a machine-learning approach to primer design, and highmultiplexing systems for deep sequencing.
INNOVATOR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .28
From DNA to Diagnosis without Delay To date, genome sequencing has
tended to rely on software-based approaches, but specialized hardware
platforms are starting to emerge that are faster and more convenient.
NEWS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
Cover: iStock / vitanovski
Above (top): iStock / rbv; (bottom): Instituto Bernabeu
www.clinicalomics.com
NEW PRODUCTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .19
MEETING ROUNDUP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .33
March 2016 Clinical OMICs
3
https://www.youtube.com/channel/UCXBPPWZv--Ne4NfAUHcc8hg
https://twitter.com/ClinicalOMICs
http://www.clinicalomics.com
Table of Contents for the Digital Edition of Clinical OMICs - Volume 3, Issue 3
Contents
Clinical OMICs - Volume 3, Issue 3
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss9
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss8
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss7
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss6
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss5
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss4
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss3
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss2
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss1
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss12
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss11
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss10
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss9
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss8
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss7
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss6
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss5
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss4
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss3
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss2
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss1
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue15
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue14
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue13
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue12
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue11
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue10
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue9
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue8
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue7
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue6
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue5
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue4
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue3
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue2
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue1
https://www.nxtbookmedia.com